ACSS2 inhibitors act as metabo-immunomodulators in triple negative breast cancer
Ontology highlight
ABSTRACT: ACSS2 inhibitors act as metabo-immunomodulators in triple negative breast cancer
PROVIDER: PRJNA835329 | ENA |
REPOSITORIES: ENA
ACCESS DATA